Literature DB >> 11473487

Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy.

G Grassi1, G Seravalle, G Bertinieri, C Turri, M L Stella, F Scopelliti, G Mancia.   

Abstract

Congestive heart failure (CHF) is characterized by a sympathetic activation and a baroreflex impairment whose degree is directly related to the clinical severity of the disease. However, whether these abnormalities vary according to the ischaemic or idiopathic dilated nature of the CHF state has not been conclusively documented. In patients with a clinically stable, chronic CHF state in New York Heart Association functional class II and III, due either to ischaemic heart disease (IHD; n=22, age 60.3+/-2.4 years, means+/-S.E.M.) or to idiopathic dilated cardiomyopathy (IDC; n=20, age 58.9+/-2.8 years), and in 30 age-matched controls, we measured arterial blood pressure (using a Finapres device), heart rate (by electrocardiogram) and postganglionic muscle sympathetic nerve traffic (by microneurography) at rest and during baroreceptor manipulation induced by the vasoactive drug-infusion technique. Blood pressure values were not significantly different in CHF patients and controls. Compared with controls, heart rate was similarly increased and left ventricular ejection fraction (by echocardiography) similarly reduced in CHF patients with IHD or IDC. Muscle sympathetic nerve traffic was significantly greater in CHF patients than in controls, and did not differ between patients with IHD or IDC (67.3+/-4.2 and 67.8+/-3.8 bursts/100 heart beats respectively). This was also the case for the degree of baroreflex impairment. These data show that CHF states due to IHD or to IDC are characterized by a similar degree of peripheral sympathetic activation and by a similar impairment of the baroreflex function. Thus the neuroadrenergic and reflex abnormalities characterizing CHF are independent of its aetiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11473487

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  14 in total

Review 1.  Parasympathetic Vagal Control of Cardiac Function.

Authors:  Jhansi Dyavanapalli; Olga Dergacheva; Xin Wang; David Mendelowitz
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

Review 2.  Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure.

Authors:  Gino Seravalle; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-03-27

3.  Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions.

Authors:  Ashbeel Roy; Mouhamed Dakroub; Geisa C S V Tezini; Yin Liu; Silvia Guatimosim; Qingping Feng; Helio C Salgado; Vania F Prado; Marco A M Prado; Robert Gros
Journal:  FASEB J       Date:  2015-10-19       Impact factor: 5.191

Review 4.  Sympathetic mechanisms, organ damage, and antihypertensive treatment.

Authors:  Guido Grassi; Gino Seravalle; Raffaella Dell'Oro; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

5.  Baseline heart rate variability predicts clinical events in heart failure patients implanted with cardiac resynchronization therapy: validation by means of related complexity index.

Authors:  Giulio Molon; Francesco Solimene; Donato Melissano; Antonio Curnis; Giuseppina Belotti; Natale Marrazzo; Jacek Marczyk; Francesco Accardi; Giovanni Raciti; Paolo Zecchi
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-10       Impact factor: 1.468

6.  Early atherosclerosis and cardiac autonomic responses to mental stress: a population-based study of the moderating influence of impaired endothelial function.

Authors:  Nadja Chumaeva; Mirka Hintsanen; Taina Hintsa; Niklas Ravaja; Markus Juonala; Olli T Raitakari; Liisa Keltikangas-Järvinen
Journal:  BMC Cardiovasc Disord       Date:  2010-03-29       Impact factor: 2.298

7.  Stress responses and baroreflex function in coronary disease.

Authors:  Gaelle Deley; Ruth D Lipman; Joseph P Kannam; Claudia Bartolini; J Andrew Taylor
Journal:  J Appl Physiol (1985)       Date:  2008-12-18

Review 8.  Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights.

Authors:  Guido Grassi; GianMaria Brambilla; Daniela Prata Pizzalla; Gino Seravalle
Journal:  Curr Hypertens Rep       Date:  2016-08       Impact factor: 5.369

Review 9.  Cholinergic activity as a new target in diseases of the heart.

Authors:  Ashbeel Roy; Silvia Guatimosim; Vania F Prado; Robert Gros; Marco A M Prado
Journal:  Mol Med       Date:  2015-01-26       Impact factor: 6.354

Review 10.  Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation--tentative prophylactic properties of vagus nerve stimulation on malignant arrhythmias in heart failure.

Authors:  Kieran E Brack; James Winter; G André Ng
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.